GlassScriptPhysician profile
Jay R Patel
NPI 1104351089
$5,775.18
in general payments reported to CMS, 2019-2025
26 companies · $2,428 in 2025
The $2,428 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.07 · 2023: $927 · 2024: $2,403 · 2025: $2,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,991 · Travel and Lodging: $2,427 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,990.80 |
| Travel and Lodging | $2,426.65 |
| Education | $339.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,842.52 | 2024-2025 | Pascal, Evoque |
| Abbott Laboratories | $1,554.67 | 2023-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Heartflow, INC. | $392.72 | 2023-2024 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $261.84 | 2023-2025 | Farxiga, Brilinta, Wainua |
| E.R. Squibb & Sons, L.L.C. | $212.17 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $195.43 | 2023-2025 | |
| Boston Scientific Corporation | $182.81 | 2024-2025 | General - Therapies |
| Atricure, INC. | $148.09 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Pfizer INC. | $133.02 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.34 | 2023 | Jardiance |
| Abiomed | $124.49 | 2023-2024 | Impella |
| Alnylam Pharmaceuticals INC. | $119.66 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $108.00 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $68.26 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.00 | 2024-2025 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $31.06 | 2024 | Azure Xt Dr Mri Surescan |
| Genzyme Corporation | $26.89 | 2025 | |
| Terumo Medical Corporation | $26.10 | 2025 | Angio-Seal |
| Bayer Healthcare Pharmaceuticals INC. | $24.94 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $24.75 | 2024 | Arcalyst |
| Amgen INC. | $22.06 | 2024 | |
| Teleflex LLC | $21.32 | 2025 | Arrow |
| Philips North America LLC | $18.65 | 2025 | Mcot |
| Janssen Pharmaceuticals, INC | $18.39 | 2024 | Xarelto |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.40 | 2024 | Caplyta |
| Chiesi USA, INC. | $16.60 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.